S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The "Smart Money" Is Ready for May 1st Are You? (Ad)
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Comprehensive Analysis of PayPal Stock
SHOCKING Crypto Leak… (Ad)
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The "Smart Money" Is Ready for May 1st Are You? (Ad)
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Comprehensive Analysis of PayPal Stock
SHOCKING Crypto Leak… (Ad)
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The "Smart Money" Is Ready for May 1st Are You? (Ad)
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Comprehensive Analysis of PayPal Stock
SHOCKING Crypto Leak… (Ad)
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The "Smart Money" Is Ready for May 1st Are You? (Ad)
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Comprehensive Analysis of PayPal Stock
SHOCKING Crypto Leak… (Ad)
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
Free Trial

Alnylam Pharmaceuticals (ALNY) Earnings Date, Estimates & Call Transcripts

→ Start loving Mondays like this (From DTI) (Ad)
Free alny Stock Alerts
$144.41
-0.75 (-0.52%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 2
Before Market Opens
Confirmed
Actual EPS
(Feb. 15)
-$1.10 Beat By $0.10
Consensus EPS
(Feb. 15)
-$1.20
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ALNY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALNY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Alnylam Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244($1.26)($0.70)($1.02) 
Q2 20244($1.38)($0.76)($1.09) 
Q3 20244($1.05)($0.76)($0.93) 
Q4 20244($1.12)($0.70)($0.88) 
FY 202416($4.81)($2.92)($3.92) 
Q1 20251($0.57)($0.57)($0.57) 
Q2 20251($0.55)($0.55)($0.55) 
Q3 20251($0.51)($0.51)($0.51) 
Q4 20251($0.36)($0.36)($0.36) 
FY 20254($1.99)($1.99)($1.99) 
Q1 20261$0.32$0.32$0.32 

ALNY Earnings Date and Information

Alnylam Pharmaceuticals last announced its quarterly earnings results on February 15th, 2024. The biopharmaceutical company reported ($1.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.20) by $0.10. The business earned $439.72 million during the quarter, compared to the consensus estimate of $439.38 million. Its quarterly revenue was up 31.2% compared to the same quarter last year. Alnylam Pharmaceuticals has generated ($3.56) earnings per share over the last year (($3.56) diluted earnings per share). Earnings for Alnylam Pharmaceuticals are expected to grow in the coming year, from ($4.54) to ($2.22) per share. Alnylam Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, May 2nd, 2024. Alnylam Pharmaceuticals will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call..

Alnylam Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Confirmed)		-------  
2/15/2024Q4 2023($1.20)($1.10)+$0.10($1.10)$439.38 million$439.72 million    
11/2/2023Q3 2023($1.61)$1.15+$2.76$1.15$406.14 million$750.53 million
8/3/2023Q2 2023($1.72)($2.21)($0.49)($2.21)$331.73 million$318.75 million
5/4/2023Q1 2023($1.97)($1.40)+$0.57($1.40)$312.53 million$319.29 million      
2/23/2023Q4 2022($2.13)($1.68)+$0.45($1.68)$312.45 million$335.04 million      
10/27/2022Q3 2022($1.86)($3.32)($1.46)($3.32)$291.81 million$264.31 million      
7/28/2022Q2 2022($1.62)($2.29)($0.67)($2.29)$256.06 million$224.80 million    
4/28/2022Q1 2022($1.93)($2.00)($0.07)($2.00)$242.82 million$186.90 million      
2/10/2022Q4 2021($1.47)($2.16)($0.69)($2.16)$233.62 million$258.10 million    
10/27/2021Q3 2021($1.51)($1.72)($0.21)($1.72)$218.69 million$187.63 million    
8/2/2021Q2 2021($1.61)($1.61)-($1.61)$193.66 million$220.55 million      
4/28/2021Q1 2021($1.75)($1.71)+$0.04($1.71)$176.93 million$177.57 million  

Alnylam Pharmaceuticals Earnings - Frequently Asked Questions

When is Alnylam Pharmaceuticals's earnings date?

Alnylam Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Thursday, May 2nd, 2024. Learn more on ALNY's earnings history.

Did Alnylam Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Alnylam Pharmaceuticals (NASDAQ:ALNY) reported ($1.10) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.20) by $0.10. Learn more on analysts' earnings estimate vs. ALNY's actual earnings.

How can I listen to Alnylam Pharmaceuticals's earnings conference call?

The conference call for Alnylam Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Alnylam Pharmaceuticals's conference call transcript?

The conference call transcript for Alnylam Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does Alnylam Pharmaceuticals generate each year?

Alnylam Pharmaceuticals (NASDAQ:ALNY) has a recorded annual revenue of $1.83 billion.

How much profit does Alnylam Pharmaceuticals generate each year?

Alnylam Pharmaceuticals (NASDAQ:ALNY) has a recorded net income of -$440.24 million. ALNY has generated -$3.56 earnings per share over the last four quarters.

What is Alnylam Pharmaceuticals's EPS forecast for next year?

Alnylam Pharmaceuticals's earnings are expected to grow from ($4.54) per share to ($2.22) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ALNY) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets